In this post, our Roundup lawyers will give you:
- an update on where things stand in the Roundup class action lawsuit in September 2024
- the likely direction the Roundup litigation will likely take moving forward and
In this post, our Roundup lawyers will give you:
Non-Hodgkin’s lymphoma (NHL) is diagnosed in over 80,000 people each year in the U.S., making it one of the more common cancer types. Recently, NHL has become one of the primary injuries in a number of class action mass torts because it has been linked to chronic exposure to certain chemicals. NHL is also at issue in many medical malpractice cases involving diagnostic errors.
This page will provide a basic medical overview of non-Hodgkin’s lymphoma and discuss its involvement in various product liability and mass tort cases.